{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:16:17Z","timestamp":1795047377199,"version":"4.10.2"},"reference-count":92,"publisher":"American Association for Cancer Research (AACR)","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2110539"],"award-info":[{"award-number":["W81XWH2110539"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT94252410551"],"award-info":[{"award-number":["HT94252410551"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM147365"],"award-info":[{"award-number":["R01GM147365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA263592"],"award-info":[{"award-number":["R37CA263592"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["U01CA253472"],"award-info":[{"award-number":["U01CA253472"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA217842"],"award-info":[{"award-number":["U01CA217842"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA251245"],"award-info":[{"award-number":["R01CA251245"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA282005"],"award-info":[{"award-number":["R01CA282005"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DE030859"],"award-info":[{"award-number":["DE030859"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The role of androgen receptor (AR) signaling in modulating antitumor immune responses has received increasing attention in recent years; however, its broader impact across diverse cancer types and between sexes remains largely unexplored. In this study, we investigated how AR activity correlates with tumor-infiltrating leukocytes, patient prognosis, and immunotherapy response across cancers and sexes. We inferred AR activity using a network-based approach across bulk RNA sequencing [RNA-seq; The Cancer Genome Atlas (TCGA)], single-cell RNA-seq (prostate cancer meta-atlas), and immunotherapy cohorts. Pathway analysis and Cox regression assessed mechanisms and survival. Immune infiltration and signatures were evaluated via TIMER and single-sample gene set enrichment analysis. Key findings were validated using digital spatial profiling and IHC. Our pan-cancer analysis of 33 TCGA cancer types revealed broad variability in AR activity, with highest observed in prostate adenocarcinoma. Genes significantly correlated with AR activity showed negative associations and were enriched in immune activation pathways. Notably, AR activity inversely correlated with leukocyte abundance and IFN\u03b3 pathway activity across tumors and sexes\u2014unlike estrogen or progesterone receptors. Longitudinal biopsy analysis in metastatic prostate cancer showed that AR inhibition enhanced immune cell and IFN\u03b3 signatures. Single-cell analysis confirmed that tumor-intrinsic AR activity inversely correlates with immune infiltration in prostate cancer. Furthermore, low AR activity is significantly associated with favorable immunotherapy responses in hormone-independent cohorts. Spatial proteomics showed a negative correlation between AR and CD45 protein in sarcoma and ovarian cancers. These findings suggest AR activity as a pan-cancer predictive biomarker of immunotherapy response and support that AR blockade in immunotherapy-refractory tumors represents a promising treatment strategy, regardless of tumor type or patient sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Tumor-associated AR activity negatively correlates with immune infiltration and immunotherapy response across cancers, independent of sex, suggesting that combining AR inhibitors with checkpoint blockade may benefit patients with immunotherapy-refractory tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0409","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:55:06Z","timestamp":1764172506000},"page":"17-35","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-1770","authenticated-orcid":false,"given":"Ya-Mei","family":"Hu","sequence":"first","affiliation":[{"name":"1Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8238-3863","authenticated-orcid":false,"given":"Faming","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5708-2794","authenticated-orcid":false,"given":"Julie N.","family":"Graff","sequence":"additional","affiliation":[{"name":"2Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon."},{"name":"3VA Portland Health Care System, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4021-8592","authenticated-orcid":false,"given":"Canping","family":"Chen","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5680-4647","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2485-7992","authenticated-orcid":false,"given":"Jayne M.","family":"Stommel","sequence":"additional","affiliation":[{"name":"2Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5290-3100","authenticated-orcid":false,"given":"Jinho","family":"Lee","sequence":"additional","affiliation":[{"name":"2Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon."},{"name":"4Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7081-0185","authenticated-orcid":false,"given":"Gabriel M.","family":"Zangirolani","sequence":"additional","affiliation":[{"name":"2Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon."},{"name":"4Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4425-0656","authenticated-orcid":false,"given":"Joshua","family":"Rose","sequence":"additional","affiliation":[{"name":"2Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon."},{"name":"4Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7416-8840","authenticated-orcid":false,"given":"George V.","family":"Thomas","sequence":"additional","affiliation":[{"name":"2Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon."},{"name":"5Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1694-3954","authenticated-orcid":false,"given":"Hui","family":"Wu","sequence":"additional","affiliation":[{"name":"6Division of Biomaterial and Biomedical Sciences, Department of Oral Rehabilitation and Biosciences, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6241-4896","authenticated-orcid":false,"given":"Adel","family":"Kardosh","sequence":"additional","affiliation":[{"name":"2Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0144-9614","authenticated-orcid":false,"given":"Gordon B.","family":"Mills","sequence":"additional","affiliation":[{"name":"2Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon."},{"name":"7Division of Oncological Sciences, Oregon Health & Science University, Portland, Oregon."},{"name":"8Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1278-0166","authenticated-orcid":false,"given":"Joshi J.","family":"Alumkal","sequence":"additional","affiliation":[{"name":"9Department of Internal Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1952-7737","authenticated-orcid":false,"given":"Amy E.","family":"Moran","sequence":"additional","affiliation":[{"name":"2Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon."},{"name":"8Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3364-8324","authenticated-orcid":false,"given":"Zheng","family":"Xia","sequence":"additional","affiliation":[{"name":"1Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon."},{"name":"2Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon."},{"name":"10Center for Biomedical Data Science, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"2026010503431281400_bib1","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1200\/JCO.2002.10.018","article-title":"Molecular biology of the androgen receptor","volume":"20","author":"Gelmann","year":"2002","journal-title":"J Clin Oncol"},{"key":"2026010503431281400_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0960-0760(97)00049-6","article-title":"Localization of functional domains in the androgen receptor","volume":"62","author":"MacLean","year":"1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026010503431281400_bib3","doi-asserted-by":"crossref","first-page":"11209","DOI":"10.1073\/pnas.0404372101","article-title":"Subfertility and defective folliculogenesis in female mice lacking androgen receptor","volume":"101","author":"Hu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010503431281400_bib4","doi-asserted-by":"crossref","first-page":"13498","DOI":"10.1073\/pnas.212474399","article-title":"Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues","volume":"99","author":"Yeh","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010503431281400_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/1008-682X.122590","article-title":"Human androgen deficiency: insights gained from androgen receptor knockout mouse models","volume":"16","author":"Rana","year":"2014","journal-title":"Asian J Androl"},{"key":"2026010503431281400_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/cancers10010022","article-title":"AR signaling in human malignancies: prostate cancer and beyond","volume":"10","author":"Antonarakis","year":"2018","journal-title":"Cancers (Basel)"},{"key":"2026010503431281400_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41586-024-07789-z","article-title":"Immune system adaptation during gender-affirming testosterone treatment","volume":"633","author":"Lakshmikanth","year":"2024","journal-title":"Nature"},{"key":"2026010503431281400_bib8","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"Aguet","year":"2020","journal-title":"Science"},{"key":"2026010503431281400_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/1096-9896(0000)9999:9999<::AID-PATH803>3.0.CO;2-W","article-title":"Localization of androgen receptor expression in human bone marrow","volume":"193","author":"Mantalaris","year":"2001","journal-title":"J Pathol"},{"key":"2026010503431281400_bib10","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1073\/pnas.1402468111","article-title":"Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation","volume":"111","author":"Kissick","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010503431281400_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","article-title":"Androgen receptor activity in T cells limits checkpoint blockade efficacy","volume":"606","author":"Guan","year":"2022","journal-title":"Nature"},{"key":"2026010503431281400_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/cimm.1997.1227","article-title":"Androgens alter B cell development in normal male mice","volume":"182","author":"Viselli","year":"1997","journal-title":"Cell Immunol"},{"key":"2026010503431281400_bib13","doi-asserted-by":"crossref","first-page":"eabq2630","DOI":"10.1126\/sciimmunol.abq2630","article-title":"Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer","volume":"7","author":"Kwon","year":"2022","journal-title":"Sci Immunol"},{"key":"2026010503431281400_bib14","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.immuni.2022.05.012","article-title":"Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity","volume":"55","author":"Yang","year":"2022","journal-title":"Immunity"},{"key":"2026010503431281400_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1158\/2159-8290.CD-24-0559","article-title":"Androgen receptor inhibition increases MHC class I expression and improves immune response in prostate cancer","volume":"15","author":"Chesner","year":"2025","journal-title":"Cancer Discov"},{"key":"2026010503431281400_bib16","doi-asserted-by":"crossref","first-page":"e1006701","DOI":"10.1371\/journal.pcbi.1006701","article-title":"New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx","volume":"15","author":"Mounir","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"2026010503431281400_bib17","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026010503431281400_bib18","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.12688\/f1000research.8923.1","article-title":"TCGA Workflow: analyze cancer genomics and epigenomics data using Bioconductor packages","volume":"5","author":"Silva","year":"2016","journal-title":"F1000Res"},{"key":"2026010503431281400_bib19","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/cancers12071943","article-title":"Pre-treatment mutational and transcriptomic landscape of responding metastatic melanoma patients to anti-PD1 immunotherapy","volume":"12","author":"Amato","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026010503431281400_bib20","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung","year":"2019","journal-title":"Nat Commun"},{"key":"2026010503431281400_bib21","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s12276-020-00493-8","article-title":"Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer","volume":"52","author":"Cho","year":"2020","journal-title":"Exp Mol Med"},{"key":"2026010503431281400_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"2026010503431281400_bib23","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1038\/s41467-021-25432-7","article-title":"Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity","volume":"12","author":"Cindy Yang","year":"2021","journal-title":"Nat Commun"},{"key":"2026010503431281400_bib24","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1038\/s41467-022-32701-6","article-title":"Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity","volume":"13","author":"Westbrook","year":"2022","journal-title":"Nat Commun"},{"key":"2026010503431281400_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"2026010503431281400_bib26","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1093\/nar\/gks042","article-title":"Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation","volume":"40","author":"McCarthy","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2026010503431281400_bib27","first-page":"1438","article-title":"From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline","volume":"5","author":"Chen","year":"2016","journal-title":"F1000Res"},{"key":"2026010503431281400_bib28","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.7150\/thno.92336","article-title":"Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression","volume":"14","author":"Zhang","year":"2024","journal-title":"Theranostics"},{"key":"2026010503431281400_bib29","doi-asserted-by":"crossref","first-page":"abe6474","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"2026010503431281400_bib30","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.ccell.2023.10.006","article-title":"Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer","volume":"41","author":"Hawley","year":"2023","journal-title":"Cancer Cell"},{"key":"2026010503431281400_bib31","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.3593","article-title":"Functional characterization of somatic mutations in cancer using network-based inference of protein activity","volume":"48","author":"Alvarez","year":"2016","journal-title":"Nat Genet"},{"key":"2026010503431281400_bib32","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"2026010503431281400_bib33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"2026010503431281400_bib34","first-page":"100141","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"2026010503431281400_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"2026010503431281400_bib36","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2026010503431281400_bib37","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res"},{"key":"2026010503431281400_bib38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol"},{"key":"2026010503431281400_bib39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep"},{"key":"2026010503431281400_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2026010503431281400_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2026010503431281400_bib42","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest"},{"key":"2026010503431281400_bib43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.coi.2016.02.001","article-title":"Disentangling the relationship between tumor genetic programs and immune responsiveness","volume":"39","author":"Bedognetti","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"2026010503431281400_bib44","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"2026010503431281400_bib45","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010503431281400_bib46","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2026010503431281400_bib47","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/bioinformatics\/btz625","article-title":"BBKNN: fast batch alignment of single cell transcriptomes","volume":"36","author":"Pola\u0144ski","year":"2020","journal-title":"Bioinformatics"},{"key":"2026010503431281400_bib48","doi-asserted-by":"crossref","first-page":"eabl5197","DOI":"10.1126\/science.abl5197","article-title":"Cross-tissue immune cell analysis reveals tissue-specific features in humans","volume":"376","author":"Dom\u00ednguez Conde","year":"2022","journal-title":"Science"},{"key":"2026010503431281400_bib49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/s12967-018-1733-y","article-title":"Implementing a comprehensive translational oncology platform: from molecular testing to actionability","volume":"16","author":"Mitri","year":"2018","journal-title":"J Transl Med"},{"key":"2026010503431281400_bib50","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J Clin Oncol"},{"key":"2026010503431281400_bib51","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.3390\/cancers13174456","article-title":"Best practices for spatial profiling for breast cancer research with the GeoMx(R) digital spatial profiler","volume":"13","author":"Bergholtz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026010503431281400_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the cox model","author":"Therneau","year":"2000"},{"key":"2026010503431281400_bib53","article-title":"A package for survival analysis in R","volume":"8-3","author":"Therneau","year":"2024","journal-title":"R Package Version3"},{"key":"2026010503431281400_bib54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/ERC-17-0417","article-title":"The role of the AR\/ER ratio in ER-positive breast cancer patients","volume":"25","author":"Rangel","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2026010503431281400_bib55","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2026010503431281400_bib56","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1200\/JCO.2018.78.2276","article-title":"T-cell-Inflamed gene-expression profile, programmed death ligand 1 expression, and tumor mutational burden predict efficacy in patients treated with pembrolizumab across 20 cancers: KEYNOTE-028","volume":"37","author":"Ott","year":"2019","journal-title":"J Clin Oncol"},{"key":"2026010503431281400_bib57","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/s12967-023-04463-2","article-title":"Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer","volume":"21","author":"Mogenet","year":"2023","journal-title":"J Transl Med"},{"key":"2026010503431281400_bib58","doi-asserted-by":"crossref","first-page":"14565","DOI":"10.1073\/pnas.251140998","article-title":"T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer","volume":"98","author":"Mercader","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010503431281400_bib59","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.4049\/jimmunol.173.10.6098","article-title":"Augmentation of T cell levels and responses induced by androgen deprivation","volume":"173","author":"Roden","year":"2004","journal-title":"J Immunol"},{"key":"2026010503431281400_bib60","first-page":"191","article-title":"Intermittent endocrine therapy and its potential for chemoprevention of prostate cancer","volume":"23","author":"Oliver","year":"1995","journal-title":"Cancer Surv"},{"key":"2026010503431281400_bib61","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41391-021-00340-5","article-title":"How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer","volume":"24","author":"Stultz","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2026010503431281400_bib62","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.1073\/pnas.1922207117","article-title":"Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance","volume":"117","author":"Alumkal","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010503431281400_bib63","doi-asserted-by":"crossref","first-page":"e20201137","DOI":"10.1084\/jem.20201137","article-title":"Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis","volume":"218","author":"Ma","year":"2021","journal-title":"J Exp Med"},{"key":"2026010503431281400_bib64","doi-asserted-by":"crossref","first-page":"7076","DOI":"10.1074\/jbc.M108255200","article-title":"Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways","volume":"277","author":"Ueda","year":"2002","journal-title":"J Biol Chem"},{"key":"2026010503431281400_bib65","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fendo.2017.00002","article-title":"Non-genomic actions of the androgen receptor in prostate cancer","volume":"8","author":"Leung","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026010503431281400_bib66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","article-title":"The translational landscape of mTOR signalling steers cancer initiation and metastasis","volume":"485","author":"Hsieh","year":"2012","journal-title":"Nature"},{"key":"2026010503431281400_bib67","doi-asserted-by":"crossref","first-page":"E4762","DOI":"10.1073\/pnas.1319948110","article-title":"Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets","volume":"110","author":"Drake","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010503431281400_bib68","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1073\/pnas.96.10.5458","article-title":"From HER2\/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells","volume":"96","author":"Yeh","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010503431281400_bib69","doi-asserted-by":"crossref","first-page":"17933","DOI":"10.1074\/jbc.M200135200","article-title":"The androgen receptor can promote beta-catenin nuclear translocation independently of adenomatous polyposis coli","volume":"277","author":"Mulholland","year":"2002","journal-title":"J Biol Chem"},{"key":"2026010503431281400_bib70","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","article-title":"Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade","volume":"155","author":"Arora","year":"2013","journal-title":"Cell"},{"key":"2026010503431281400_bib71","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41591-020-01168-7","article-title":"The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer","volume":"27","author":"Hickey","year":"2021","journal-title":"Nat Med"},{"key":"2026010503431281400_bib72","doi-asserted-by":"crossref","first-page":"78545","DOI":"10.18632\/oncotarget.20827","article-title":"Prognostic relevance of androgen receptor expression in renal cell carcinomas","volume":"8","author":"Foersch","year":"2017","journal-title":"Oncotarget"},{"key":"2026010503431281400_bib73","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.ygeno.2019.11.005","article-title":"The androgen receptor expression and association with patient\u2019s survival in different cancers","volume":"112","author":"Hu","year":"2020","journal-title":"Genomics"},{"key":"2026010503431281400_bib74","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/01.ju.0000108040.14303.c2","article-title":"Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors","volume":"171","author":"Langner","year":"2004","journal-title":"J Urol"},{"key":"2026010503431281400_bib75","doi-asserted-by":"crossref","first-page":"510.e19","DOI":"10.1016\/j.urology.2013.10.022","article-title":"The expression and evaluation of androgen receptor in human renal cell carcinoma","volume":"83","author":"Zhu","year":"2014","journal-title":"Urology"},{"key":"2026010503431281400_bib76","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11255-014-0834-7","article-title":"Androgen receptor immunohistochemistry in genitourinary neoplasms","volume":"47","author":"Williams","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"2026010503431281400_bib77","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.juro.2015.03.078","article-title":"Increased expression of androgen receptor mRNA in human renal cell carcinoma cells is associated with poor prognosis in patients with localized renal cell carcinoma","volume":"194","author":"Ha","year":"2015","journal-title":"J Urol"},{"key":"2026010503431281400_bib78","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/PAT.0b013e3283652c7a","article-title":"Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients","volume":"45","author":"Noh","year":"2013","journal-title":"Pathology"},{"key":"2026010503431281400_bib79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12672-019-0358-9","article-title":"Estrogen signaling in endometrial cancer: a key oncogenic pathway with several open questions","volume":"10","author":"Rodriguez","year":"2019","journal-title":"Horm Cancer"},{"key":"2026010503431281400_bib80","doi-asserted-by":"crossref","first-page":"49289","DOI":"10.18632\/oncotarget.10334","article-title":"Androgen receptor as potential therapeutic target in metastatic endometrial cancer","volume":"7","author":"Tangen","year":"2016","journal-title":"Oncotarget"},{"key":"2026010503431281400_bib81","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41586-022-04833-8","article-title":"Androgen receptor blockade promotes response to BRAF\/MEK-targeted therapy","volume":"606","author":"Vellano","year":"2022","journal-title":"Nature"},{"key":"2026010503431281400_bib82","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1158\/1055-9965.EPI-08-1118","article-title":"Sex disparities in cancer incidence by period and age","volume":"18","author":"Cook","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026010503431281400_bib83","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.3390\/ijms24043766","article-title":"\u201cToxic masculinity\u201d: what is known about the role of androgen receptors in head and neck squamous cell carcinoma","volume":"24","author":"\u010conka\u0161","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026010503431281400_bib84","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/PAS.0b013e3180caa099","article-title":"Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients","volume":"31","author":"Williams","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"2026010503431281400_bib85","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3389\/fonc.2019.00701","article-title":"First line androgen deprivation therapy vs. chemotherapy for patients with androgen receptor positive recurrent or metastatic salivary gland carcinoma-A retrospective study","volume":"9","author":"Viscuse","year":"2019","journal-title":"Front Oncol"},{"key":"2026010503431281400_bib86","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41523-024-00697-5","article-title":"Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+\/Her2- breast cancer","volume":"10","author":"Elias","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"2026010503431281400_bib87","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front Immunol"},{"key":"2026010503431281400_bib88","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-gamma pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"2026010503431281400_bib89","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ccell.2020.08.005","article-title":"Conserved interferon-gamma signaling drives clinical response to immune checkpoint blockade therapy in melanoma","volume":"38","author":"Grasso","year":"2020","journal-title":"Cancer Cell"},{"key":"2026010503431281400_bib90","doi-asserted-by":"crossref","first-page":"e003687","DOI":"10.1136\/jitc-2021-003687","article-title":"Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature","volume":"10","author":"Bertucci","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026010503431281400_bib91","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41591-021-01600-6","article-title":"Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial","volume":"28","author":"Powles","year":"2022","journal-title":"Nat Med"},{"key":"2026010503431281400_bib92","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/1078-0432.CCR-22-2812","article-title":"Phase I study of androgen deprivation therapy in combination with anti-PD-1 in melanoma patients pretreated with anti-PD-1","volume":"29","author":"Robert","year":"2023","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0409\/3703541\/crc-25-0409.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/1\/17\/3723263\/crc-25-0409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/1\/17\/3723263\/crc-25-0409.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T08:43:32Z","timestamp":1767602612000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/1\/17\/771449\/Elevated-Tumor-Associated-Androgen-Receptor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0409","relation":{},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}